Clinical trials
Completed trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4,160 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 6 |
| 2002 | 19 |
| 2003 | 61 |
| 2004 | 69 |
| 2005 | 115 |
| 2006 | 198 |
| 2007 | 230 |
| 2008 | 260 |
| 2009 | 226 |
| 2010 | 227 |
| 2011 | 226 |
| 2012 | 193 |
| 2013 | 148 |
| 2014 | 156 |
| 2015 | 164 |
| 2016 | 169 |
| 2017 | 216 |
| 2018 | 214 |
| 2019 | 188 |
| 2020 | 178 |
| 2021 | 219 |
| 2022 | 180 |
| 2023 | 184 |
| 2024 | 144 |
| 2025 | 98 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4,160 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Post Graduate Institute of Medical Education and Research, Chandigarh | 149 |
| Novartis Pharmaceuticals | 133 |
| AstraZeneca | 124 |
| Institute of Liver and Biliary Sciences, India | 116 |
| Novo Nordisk A/S | 116 |
| GlaxoSmithKline | 113 |
| Dr. Reddy's Laboratories Limited | 98 |
| Eli Lilly and Company | 98 |
| Pfizer | 97 |
| Sanofi | 80 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 314 |
| Diabetes Mellitus | 154 |
| Breast Neoplasms | 98 |
| COVID-19 | 62 |
| Carcinoma, Non-Small-Cell Lung | 61 |
| Neoplasms | 57 |
| Schizophrenia | 54 |
| Pulmonary Disease, Chronic Obstructive | 53 |
| Arthritis, Rheumatoid | 49 |
| HIV Infections | 47 |
Trials
Showing 1 to 25 of 4,160. Each trial links to its page on Pharma Observatory.
4,060 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.